Trial no.:
|
PACTR201710000932829 |
Date of Approval:
|
07/11/2014 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
A RCT comparing eMPC to paper-based model with regards to glucose control in trauma ICU patients |
Official scientific title |
Insulin therapy and glucose control in ICU: a prospective, randomised, controlled trial comparing enhanced model predictive control to paper-based method in critically ill trauma patients |
Brief summary describing the background
and objectives of the trial
|
Glucose control (GC) has been shown to improve outcomes in critically ill patients by reducing the incidence of critical-ilness induced dysglycaemia. There is a shortage of trials in a sub-group of trauma patients within this population. GC by means of paper-based insulin infusion protocols is difficult to achieve - they are often complicated, are prone to human error, not well adhered to, and increase nursing workload. Computer decision support systems (of which enhanced model predictive control is one type) have been developed with the goal of improving the efficiency and safety of GC whilst reducing the nursing workload and increasing compliance. This trial aims to compare our current paper-based standard of care for GC in critically ill trauma patients to an eMPC algorithm. Primary end point will be 1)SG variability. Secondary end points will be 1)average time spent within target range 2)overall mean SG levels 3)time spent above target range 4)SG sampling interval. The trial will be underpowered to use hypoglycaemia as a primary end-point, but the incidence thereof will still be commented on. We hypothesise that the eMPC will out-perform our current paper-based standard of care with regards to efficacy and reduction of nursing workload. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Glucose control in critically ill trauma patients,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
05/01/2015 |
Actual trial start date |
01/07/2016 |
Anticipated date of last follow up |
31/12/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|